Published in Virchows Arch B Cell Pathol on November 03, 1977
In vivo models of primary brain tumors: pitfalls and perspectives. Neuro Oncol (2012) 1.21
Ultrastructural findings in so-called ependymal rat tumors induced by transplacental administration of ethylnitrosourea (ENU). Acta Neuropathol (1982) 0.86
The potential origin of glioblastoma initiating cells. Front Biosci (Schol Ed) (2012) 0.78
Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01
Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology (1994) 4.24
Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet (1999) 4.02
Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci (1989) 4.01
Prion dementia without characteristic pathology. Lancet (1990) 3.66
Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett (1998) 3.26
Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Nature (1996) 3.09
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol (2002) 3.02
Neuronal loss in the frontal cortex in HIV infection. Lancet (1991) 2.71
Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol (1996) 2.68
Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci U S A (2000) 2.50
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology (2001) 1.95
Diagnosing dementia: do we get it right? BMJ (1988) 1.85
Brain capillary endothelial cells in vitro lack surface IgG Fc receptors. Neurosci Lett (1986) 1.74
Cellular pathology of multiple system atrophy: a review. J Neurol Neurosurg Psychiatry (1994) 1.60
Diagnostic criteria for corticobasal degeneration. J Neurol Neurosurg Psychiatry (2000) 1.48
Semantic dementia with ubiquitin-positive tau-negative inclusion bodies. Brain (2000) 1.43
The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain (1994) 1.41
Recommended minimum data to be collected in research studies on Alzheimer's disease. The MRC (UK) Alzheimer's Disease Workshop Steering Committee. J Neurol Neurosurg Psychiatry (1989) 1.41
The potential for strategies using micronutrients and heterocyclic drugs to treat invasive gliomas. Acta Neurochir (Wien) (2003) 1.40
The fine structure of periventricular pleomorphic gliomas induced transplacentally by N-ethyl-N-nitrosourea in BD-IX rats. With a note on their origin. J Neurol Sci (1972) 1.38
Brain tissue banks in psychiatric and neurological research. J Clin Pathol (1996) 1.38
Characterization of the human cell line TE671. Carcinogenesis (1989) 1.34
Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42(43). Ann Neurol (1996) 1.32
Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst (1998) 1.25
Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy. J Neurol Sci (1992) 1.21
The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours. Neuropathol Appl Neurobiol (2002) 1.20
Studies of the morphology and tumorigenicity of experimental brain tumours in tissue culture. Br J Exp Pathol (1976) 1.20
Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages. Neuroreport (2001) 1.19
CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res (1994) 1.18
Adhesion of lymphocytes to cerebral microvascular cells: effects of interferon-gamma, tumour necrosis factor and interleukin-1. Immunology (1988) 1.17
The origin of experimental brain tumours: a sequential study. Experientia (1976) 1.17
The development of experimental brain tumours. A sequential light and electron microscope study of the subependymal plate. I. Early lesions (abnormal cell clusters). Acta Neuropathol (1979) 1.14
Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry (1989) 1.14
Is the neuropathology of new variant Creutzfeldt-Jakob disease and kuru similar? Lancet (1997) 1.14
The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis. J Neurooncol (2001) 1.13
Multiple system atrophy/progressive supranuclear palsy: alpha-Synuclein, synphilin, tau, and APOE. Neurology (2000) 1.13
Prion protein immunocytochemistry--UK five centre consensus report. Neuropathol Appl Neurobiol (1997) 1.13
Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. Am J Pathol (1996) 1.12
Microglia and the pathogenesis of spongiform encephalopathies. Brain Res Brain Res Rev (2001) 1.11
Distribution and fine structural analysis of undifferentiated cells in the primate subependymal layer. J Anat (1991) 1.10
Pick's disease is associated with mutations in the tau gene. Ann Neurol (2000) 1.10
Neuronal number and volume alterations in the neocortex of HIV infected individuals. J Neurol Neurosurg Psychiatry (1993) 1.09
The vasculature of experimental brain tumours. Part 1. A sequential light and electron microscope study of angiogenesis. J Neurol Sci (1981) 1.09
The NG2 chondroitin sulfate proteoglycan: role in malignant progression of human brain tumours. Int J Dev Neurosci (1999) 1.07
Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. J Neuropathol Exp Neurol (1999) 1.07
The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells. Br J Cancer (2000) 1.07
Neuronal loss in the hippocampus in Huntington's disease: a comparison with HIV infection. J Neurol Neurosurg Psychiatry (1993) 1.05
Chemical carcinogenesis in the nervous system. Int Rev Exp Pathol (1976) 1.05
Quantitative analysis of tau isoform transcripts in sporadic tauopathies. Brain Res Mol Brain Res (2005) 1.04
beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease. Neuropathol Appl Neurobiol (1999) 1.04
Recombinant nef HIV-IIIB protein is toxic to human neurons in culture. Brain Res (2000) 1.04
HIV-associated brain pathology in the United Kingdom: an epidemiological study. AIDS (1997) 1.03
Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1. Br J Cancer (1994) 1.02
Chlorimipramine: a novel anticancer agent with a mitochondrial target. Biochem Biophys Res Commun (2005) 1.01
Alien hand sign in association with Alzheimer's histopathology. J Neurol Neurosurg Psychiatry (1993) 1.01
A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies. Ann Neurol (2000) 1.00
Migration and invasion in brain neoplasms. Curr Neurol Neurosci Rep (2001) 0.99
Immunocytochemistry of cerebellar astrocytomas: with a special note on Rosenthal fibres. Acta Neuropathol (1985) 0.98
Extracellular matrix proteins inhibit proliferation, upregulate migration and induce morphological changes in human glioma cell lines. Eur J Cancer (1995) 0.96
The role of glutamine synthetase in the diagnosis of cerebral tumours. Neuropathol Appl Neurobiol (1982) 0.96
Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochemistry and zymography in human primary brain tumours. Int J Oncol (1998) 0.96
Correlation of MRI and neuropathology in AIDS. J Neurol Neurosurg Psychiatry (1997) 0.96
Vascular endothelial growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells in vitro. Cancer Lett (1996) 0.95
Hyaluronic acid/CD44H interaction induces cell detachment and stimulates migration and invasion of human glioma cells in vitro. Int J Cancer (1995) 0.94
The vasculature of experimental brain tumours. Part 2. A quantitative assessment of morphological abnormalities. J Neurol Sci (1981) 0.94
Macrophages in brain tumours induced transplacentally by N-ethyl-N-nitrosourea in rats: an electron-microscope study. J Pathol (1975) 0.94
Neuronal loss and neurofibrillary degeneration in the hippocampal cortex in late-onset sporadic Alzheimer's disease. Psychiatry Clin Neurosci (2000) 0.94
Cholinergic system and memory in the rat: effects of chronic ethanol, embryonic basal forebrain brain transplants and excitotoxic lesions of cholinergic basal forebrain projection system. Neuroscience (1989) 0.94
A quantitative study of the pathological lesions in the neocortex and hippocampus of twelve patients with corticobasal degeneration. Exp Neurol (2000) 0.93
Cell lines (VMDk) derived from a spontaneous murine astrocytoma. Morphological and immunocytochemical characterization. J Neurol Sci (1983) 0.93
An electron microscope study of reacting astrocytes in gliomas induced by n-ethyl-n-nitrosourea in rats. Acta Neuropathol (1974) 0.93
Cerebral damage in paraquat poisoning. Histopathology (1980) 0.92
Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease. Neurosci Lett (1997) 0.92
Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro. Neuropathol Appl Neurobiol (2001) 0.92
Structural and functional changes in skeletal muscle in anorexia nervosa. Acta Neuropathol (1998) 0.91
Cholinergic-rich brain transplants reverse alcohol-induced memory deficits. Nature (1988) 0.91
Ultrastructural examination is essential for diagnosis of papillary meningioma. Histopathology (2001) 0.91
Cases of Alzheimer's disease due to deletion of exon 9 of the presenilin-1 gene show an unusual but characteristic beta-amyloid pathology known as 'cotton wool' plaques. Neuropathol Appl Neurobiol (2001) 0.91
NG2 precursor cells in neoplasia: functional, histogenesis and therapeutic implications for malignant brain tumours. J Neurocytol (2003) 0.91
The fine structure of blood vessels in ethylnitrosourea-induced tumours of the rat nervous system: with special reference to the breakdown of the blood-brain barrier. Br J Exp Pathol (1976) 0.91
Cell proliferation in the subependymal layer of the postnatal marmoset, Callithrix jacchus. Brain Res Dev Brain Res (1990) 0.91
A quantitative study of the pathological changes in the cerebellum in 15 cases of variant Creutzfeldt-Jakob disease (vCJD). Neuropathol Appl Neurobiol (2009) 0.90
What does the study of the spatial patterns of pathological lesions tell us about the pathogenesis of neurodegenerative disorders? Neuropathology (2001) 0.90
Spatial correlations between the vacuolation, prion protein deposits, and surviving neurons in the cerebral cortex in sporadic Creutzfeldt-Jakob disease. Neuropathology (2001) 0.89
The development of experimental brain tumours a sequential light and electron microscope study of the subependymal plate. II. Microtumours. Acta Neuropathol (1979) 0.88
Beta A4 deposition in the temporal cortex of adults with Down's syndrome. J Neurol Sci (1992) 0.88
Purkinje cell loss and astrocytosis in the cerebellum in familial and sporadic Alzheimer's disease. Neurosci Lett (1996) 0.88
Fine structural localisation of acid phosphatase in neural tumours induced by N-ethyl-N-nitrosourea in rats. Acta Neuropathol (1974) 0.88
Cellular heterogeneity in an ethylnitrosourea-induced glioma: malignancy, karyology and other properties of tumour cell types. Br J Exp Pathol (1979) 0.88
The role of integrin receptors in aspects of glioma invasion in vitro. Int J Dev Neurosci (1999) 0.88